Peak Planning Group LLC Invests $676,000 in Procter & Gamble Company (The) $PG

Peak Planning Group LLC acquired a new position in Procter & Gamble Company (The) (NYSE:PGFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,720 shares of the company’s stock, valued at approximately $676,000.

A number of other hedge funds have also recently made changes to their positions in PG. Carson Advisory Inc. grew its stake in Procter & Gamble by 0.5% in the fourth quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock worth $1,738,000 after purchasing an additional 65 shares in the last quarter. Trilogy Capital Inc. grew its stake in Procter & Gamble by 1.1% in the fourth quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock worth $901,000 after purchasing an additional 67 shares in the last quarter. Cary Street Partners Investment Advisory LLC grew its stake in Procter & Gamble by 1.8% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock worth $549,000 after purchasing an additional 67 shares in the last quarter. Lorne Steinberg Wealth Management Inc. grew its stake in Procter & Gamble by 2.7% in the fourth quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock worth $376,000 after purchasing an additional 68 shares in the last quarter. Finally, Grant Street Asset Management Inc. grew its stake in Procter & Gamble by 2.7% in the fourth quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock worth $376,000 after purchasing an additional 69 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.8%

Shares of NYSE PG opened at $149.47 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $348.04 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 6.45 and a beta of 0.39. The stock’s fifty day simple moving average is $144.63 and its two-hundred day simple moving average is $147.70. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.03. The business had revenue of $21.24 billion for the quarter, compared to analysts’ expectations of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were given a dividend of $1.0885 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 2.9%. Procter & Gamble’s payout ratio is 63.60%.

Analyst Upgrades and Downgrades

PG has been the topic of several research analyst reports. Morgan Stanley dropped their price objective on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Wells Fargo & Company increased their price objective on Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a research note on Monday, April 27th. Evercore set a $162.00 price objective on Procter & Gamble in a research note on Monday, April 27th. The Goldman Sachs Group dropped their price objective on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. Finally, Piper Sandler increased their price objective on Procter & Gamble from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Friday, April 24th. Eleven investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $160.78.

Read Our Latest Research Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.